Skip to content
PubMed This is a summary of 101 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 101 referenced papers

Top Authors

Randy Taplitz
City of Hope
Christopher R. Flowers
Emory University
Areej El‐Jawahri
Harvard University
Jennifer S. Temel
Massachusetts General Hospital
Bin Cao
Chinese Academy of Medical Sciences & Peking Union Medical College
Pedro Ventura‐Aguiar
Hospital Clínic de Barcelona
Eric A. Engels
National Cancer Institute
Philip F. Halloran
Johns Hopkins University
Elena Guillén
Hospital Clínic de Barcelona
Ali Kırık
Balıkesir University

Top Institutions

Ranked by publications Top 10 institutions
07

Chinese Academy of Medical Sciences & Peking Union Medical College

Beijing, China

41 papers

References

References (101)
  1. 1

    Twelve-Month and Five-Year Analyses of Risk Factors for New-Onset Diabetes After Transplantation in a Group of Patients Homogeneous for Immunosuppression.

    Dedinská I, Laca Ĺ, Miklušica M, et al.

    Transplantation proceedings 2015; (47(6)):1831-9.

    PMID: 26293059
  2. 2

    Risk of Colorectal Cancer After Solid Organ Transplantation in the United States.

    Safaeian M, Robbins HA, Berndt SI, et al.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2016; (16(3)):960-7 doi:10.1111/ajt.13549.

    PMID: 26731613
  3. 3

    Resilience is associated with low psychological distress in renal transplant recipients.

    Tian X, Gao Q, Li G, et al.

    General hospital psychiatry 2016; (39()):86-90.

    PMID: 26805002
  4. 4

    Indirect treatment comparison of belatacept versus tacrolimus from a systematic review of immunosuppressive therapies for kidney transplant patients.

    Muduma G, Hart WM, Patel S, Odeyemi AO

    Current medical research and opinion 2016; (32(6)):1065-72 doi:10.1185/03007995.2016.1157463.

    PMID: 26907083
  5. 5

    Immunization practices in solid organ transplant recipients.

    Miyairi I, Funaki T, Saitoh A

    Vaccine 2016; (34(16)):1958-64.

    PMID: 26954107
  6. 6

    Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.

    Pinho A, Gouveia M, Cardoso JC, et al.

    Anais brasileiros de dermatologia 2016; (91(4)):455-62.

    PMID: 27579740
  7. 7

    Costimulatory Blockade and Use of mTOR Inhibitors: Avoiding Injury Part 2.

    Wojciechowski D, Vincenti F

    Advances in chronic kidney disease 2016; (23(5)):306-311 doi:10.1053/j.ackd.2016.09.004.

    PMID: 27742385
  8. 8

    Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension.

    Hošková L, Málek I, Kopkan L, Kautzner J

    Physiological research 2017; (66(2)):167-180 doi:10.33549/physiolres.933332.

    PMID: 27982677
  9. 9

    Comprehensive Analysis of Transcript Changes Associated With Allograft Rejection: Combining Universal and Selective Features.

    Halloran PF, Venner JM, Famulski KS

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017; (17(7)):1754-1769 doi:10.1111/ajt.14200.

    PMID: 28101959
  10. 10

    A retrospective study to describe the epidemiology and outcomes of opportunistic infections after abdominal organ transplantation.

    Helfrich M, Dorschner P, Thomas K, et al.

    Transplant infectious disease : an official journal of the Transplantation Society 2017; (19(3)) doi:10.1111/tid.12691.

    PMID: 28273393
  11. 11

    Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.

    Colombini E, Guzzo I, Morolli F, et al.

    Pediatric nephrology (Berlin, Germany) 2017; (32(8)):1433-1442 doi:10.1007/s00467-017-3627-2.

    PMID: 28280938
  12. 12

    Scrub typhus meningitis in a renal transplant recipient.

    Dhanapriya J, Dineshkumar T, Sakthirajan R, et al.

    Indian journal of nephrology 2017; (27(2)):151-153 doi:10.4103/0971-4065.181883.

    PMID: 28356672
  13. 13

    A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation.

    de Graav GN, Baan CC, Clahsen-van Groningen MC, et al.

    Transplantation 2017; (101(10)):2571-2581 doi:10.1097/TP.0000000000001755.

    PMID: 28403127
  14. 14

    Effect of Inpatient Palliative Care During Hematopoietic Stem-Cell Transplant on Psychological Distress 6 Months After Transplant: Results of a Randomized Clinical Trial.

    El-Jawahri A, Traeger L, Greer JA, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017; (35(32)):3714-3721 doi:10.1200/JCO.2017.73.2800.

    PMID: 28926288
  15. 15

    Late presentation of Pneumocystis jirovecii pneumonia after renal transplant: A case report.

    Prasad P, Lo KB, Ram P

    Medical mycology case reports 2018; (20()):33-34 doi:10.1016/j.mmcr.2018.01.006.

    PMID: 29487779
  16. 16

    Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.

    Werbel WA, Ison MG, Angarone MP, et al.

    Transplant infectious disease : an official journal of the Transplantation Society 2018; (20(3)):e12876 doi:10.1111/tid.12876.

    PMID: 29512868
  17. 17

    Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation.

    Pittet LF, Verolet CM, McLin VA, et al.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2019; (19(3)):844-854 doi:10.1111/ajt.15101.

    PMID: 30171797
  18. 18

    Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update.

    Taplitz RA, Kennedy EB, Bow EJ, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018; (36(30)):3043-3054 doi:10.1200/JCO.18.00374.

    PMID: 30179565
  19. 19

    The expanding spectrum of antibody-mediated rejection: Should we include cases where no anti-HLA donor-specific antibody is detected?

    Randhawa P, Roufosse C

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2019; (19(3)):622-624 doi:10.1111/ajt.15114.

    PMID: 30203616
  20. 20

    New-Onset Diabetes After Transplantation: Comparison Between a Cyclosporine-Based and a Tacrolimus-Based Immunosuppressive Regimen.

    Zolota A, Miserlis G, Solonaki F, et al.

    Transplantation proceedings 2018; (50(10)):3386-3391 doi:10.1016/j.transproceed.2018.08.037.

    PMID: 30577210
  21. 21

    Metastasis of cutaneous squamous cell carcinoma in organ transplant recipients and the immunocompetent population: is there a difference? a systematic review and meta-analysis.

    Genders RE, Weijns ME, Dekkers OM, Plasmeijer EI

    Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(5)):828-841 doi:10.1111/jdv.15396.

    PMID: 30793804
  22. 22

    Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation.

    Fujimoto A, Hiramoto N, Yamasaki S, et al.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019; (25(7)):1441-1449 doi:10.1016/j.bbmt.2019.02.016.

    PMID: 30794929
  23. 23

    Nocardia infections in solid organ transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation.

    Restrepo A, Clark NM,

    Clinical transplantation 2019; (33(9)):e13509 doi:10.1111/ctr.13509.

    PMID: 30817024
  24. 24

    Recipients' Experiences after Organ Transplantation.

    Sheikhalipour Z, Zamanzadeh V, Borimnejad L, et al.

    International journal of organ transplantation medicine 2018; (9(2)):88-96.

    PMID: 30834093
  25. 25

    Management of dyslipidemia in adult solid organ transplant recipients.

    Warden BA, Duell PB

    Journal of clinical lipidology 2019; (13(2)):231-245 doi:10.1016/j.jacl.2019.01.011.

    PMID: 30928441
  26. 26

    Post-transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer Group.

    O'Neill JP, Sexton DJ, O'Leary E, et al.

    Clinical transplantation 2019; (33(10)):e13669 doi:10.1111/ctr.13669.

    PMID: 31310037
  27. 27

    The promise of a prophylactic Epstein-Barr virus vaccine.

    Balfour HH, Schmeling DO, Grimm-Geris JM

    Pediatric research 2020; (87(2)):345-352 doi:10.1038/s41390-019-0591-5.

    PMID: 31641280
  28. 28

    Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors.

    Petrara MR, Serraino D, Di Bella C, et al.

    Cancer letters 2020; (469()):323-331 doi:10.1016/j.canlet.2019.10.045.

    PMID: 31693921
  29. 29

    Safety and Efficacy of Steroid Pulse Therapy for Acute Loss of FEV1 in Lung Transplant Recipients After Exclusion of Acute Cellular Rejection.

    Munker D, Arnold P, Veit T, et al.

    Transplantation proceedings 2020; (52(1)):309-314 doi:10.1016/j.transproceed.2019.10.013.

    PMID: 31926742
  30. 30

    Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?

    Guillen E, Pineiro GJ, Revuelta I, et al.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2020; (20(7)):1875-1878 doi:10.1111/ajt.15874.

    PMID: 32198834
  31. 31

    Malignancy after lung transplantation.

    Shtraichman O, Ahya VN

    Annals of translational medicine 2020; (8(6)):416 doi:10.21037/atm.2020.02.126.

    PMID: 32355860
  32. 32

    Humoral autoimmunity after solid organ transplantation: Germinal ideas may not be natural.

    Siu JHY, Motallebzadeh R, Pettigrew GJ

    Cellular immunology 2020; (354()):104131 doi:10.1016/j.cellimm.2020.104131.

    PMID: 32563029
  33. 33

    Postoperative renal impairment is associated with increased length of stay for incisional hernia repair after liver transplantation.

    Butler JR, O'Brien DC, Kays JK, et al.

    Surgery open science 2019; (1(2)):69-73 doi:10.1016/j.sopen.2019.06.002.

    PMID: 32754695
  34. 34

    COVID-19 in Renal Transplant Patient Presenting With Active Typical Symptoms and Resolved Atypical Symptoms.

    Adapa S, Konala VM, Naramala S, et al.

    Journal of investigative medicine high impact case reports 2020; (8()):2324709620949307 doi:10.1177/2324709620949307.

    PMID: 32779481
  35. 35

    A community divided: Post-transplant live vaccine practices among Society of Pediatric Liver Transplantation (SPLIT) centers.

    Kemme S, Sundaram SS, Curtis DJ, et al.

    Pediatric transplantation 2020; (24(7)):e13804 doi:10.1111/petr.13804.

    PMID: 32845536
  36. 36

    Psychological functioning and psychosocial issues in pediatric kidney transplant recipients.

    Amatya K, Monnin K, Steinberg Christofferson E

    Pediatric transplantation 2021; (25(1)):e13842 doi:10.1111/petr.13842.

    PMID: 33012109
  37. 37

    An E-Learning Program Improves Patients' Knowledge After Lung Transplantation.

    Guldager TB, Hyldgaard C, Hilberg O, Bendstrup E

    Telemedicine journal and e-health : the official journal of the American Telemedicine Association 2021; (27(7)):800-806 doi:10.1089/tmj.2020.0101.

    PMID: 33035148
  38. 38

    Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial.

    Ahlenstiel-Grunow T, Liu X, Schild R, et al.

    Journal of the American Society of Nephrology : JASN 2021; (32(2)):502-516 doi:10.1681/ASN.2020050645.

    PMID: 33323473
  39. 39

    Association of British Clinical Diabetologists and Renal Association guidelines on the detection and management of diabetes post solid organ transplantation.

    Chowdhury TA, Wahba M, Mallik R, et al.

    Diabetic medicine : a journal of the British Diabetic Association 2021; (38(6)):e14523 doi:10.1111/dme.14523.

    PMID: 33434362
  40. 40

    M2 Macrophages Serve as Critical Executor of Innate Immunity in Chronic Allograft Rejection.

    Zhang H, Li Z, Li W

    Frontiers in immunology 2021; (12()):648539 doi:10.3389/fimmu.2021.648539.

    PMID: 33815407
  41. 41

    Belatacept in renal transplantation in comparison to tacrolimus and molecular understanding of resistance pattern: Meta-analysis and systematic review.

    Kumar J, Reccia I, Virdis F, et al.

    World journal of transplantation 2021; (11(3)):70-86 doi:10.5500/wjt.v11.i3.70.

    PMID: 33816147
  42. 42

    The patient perspective in the era of personalized medicine: What about scanxiety?

    Custers JAE, Davis L, Messiou C, et al.

    Cancer medicine 2021; (10(9)):2943-2945 doi:10.1002/cam4.3889.

    PMID: 33837668
  43. 43

    Serum bile acid levels assist the prediction of biliary stricture and survival after liver transplantation in children.

    Wu JF, Boo YA, Ho MC, et al.

    European journal of pediatrics 2021; (180(8)):2539-2547 doi:10.1007/s00431-021-04098-9.

    PMID: 33963902
  44. 44

    Intestinal Transplantation at a Single Institution in Japan.

    Kudo H, Wada M, Sasaki H, et al.

    Transplantation proceedings 2021; (53(6)):2040-2045 doi:10.1016/j.transproceed.2021.06.021.

    PMID: 34266655
  45. 45

    Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation.

    Feingold B, Rose-Felker K, West SC, et al.

    Pediatric transplantation 2022; (26(1)):e14124 doi:10.1111/petr.14124.

    PMID: 34420244
  46. 46

    Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant.

    Lindsay J, Othman J, Yong MK, et al.

    Transplant infectious disease : an official journal of the Transplantation Society 2021; (23(5)):e13719 doi:10.1111/tid.13719.

    PMID: 34453768
  47. 47

    Post-Transplant Cardiovascular Disease.

    Birdwell KA, Park M

    Clinical journal of the American Society of Nephrology : CJASN 2021; (16(12)):1878-1889 doi:10.2215/CJN.00520121.

    PMID: 34556500
  48. 48

    Belatacept rescue therapy of CNI-induced nephrotoxicity, meta-analysis.

    El Hennawy H, Safar O, Al Faifi AS, et al.

    Transplantation reviews (Orlando, Fla.) 2021; (35(4)):100653 doi:10.1016/j.trre.2021.100653.

    PMID: 34597943
  49. 49

    Advanced Leiomyosarcoma of the Retroperitoneal Space in a Kidney Transplant Recipient with a History of Peritoneal Dialysis: A Case Report.

    Kaźmierczak O, Kozaczka A, Kolonko A, et al.

    The American journal of case reports 2021; (22()):e933267 doi:10.12659/AJCR.933267.

    PMID: 34695070
  50. 50

    The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

    Sanders JF, Bemelman FJ, Messchendorp AL, et al.

    Transplantation 2022; (106(4)):821-834 doi:10.1097/TP.0000000000003983.

    PMID: 34753894
  51. 51

    Tacrolimus-induced acute pancreatitis and diabetic ketoacidosis (DKA) in pediatric kidney transplant recipient.

    Mazumder MA, Gulati S, Narula AS, et al.

    Pediatric transplantation 2022; (26(2)):e14194 doi:10.1111/petr.14194.

    PMID: 34854174
  52. 52

    The role of the electrocardiogram in the recognition of cardiac transplant rejection: A systematic review and meta-analysis.

    Hashim HT, Ramadhan MA, Ahmad S, et al.

    Clinical cardiology 2022; (45(3)):258-264 doi:10.1002/clc.23783.

    PMID: 35066923
  53. 53

    Organization of Post-Transplant Care and the 5-Year Outcomes of Kidney Transplantation.

    Szymańska A, Mucha K, Kosieradzki M, et al.

    International journal of environmental research and public health 2022; (19(4)) doi:10.3390/ijerph19042010.

    PMID: 35206198
  54. 54

    Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation.

    Asleh R, Alnsasra H, Habermann TM, et al.

    Frontiers in cardiovascular medicine 2022; (9()):787975 doi:10.3389/fcvm.2022.787975.

    PMID: 35282339
  55. 55

    Risk factors for non-melanoma skin cancer development in renal transplant recipients: a 40 year retrospective study in Croatia.

    Bašić-Jukić N, Borlinić T, Tešanović D, et al.

    Croatian medical journal 2022; (63(2)):148-155.

    PMID: 35505648
  56. 56

    New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy.

    Chaitou AR, Valmiki S, Valmiki M, et al.

    Cureus 2022; (14(3)):e23635 doi:10.7759/cureus.23635.

    PMID: 35510006
  57. 57

    Metabolic Syndrome-Related Kidney Injury: A Review and Update.

    Lin L, Tan W, Pan X, et al.

    Frontiers in endocrinology 2022; (13()):904001 doi:10.3389/fendo.2022.904001.

    PMID: 35813613
  58. 58

    Targeting Calcineurin Inhibitor-Induced Arterial Hypertension in Liver Transplanted Children Using Hydrochlorothiazide.

    Hartleif S, Baier H, Kumpf M, et al.

    The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 2022; (27(5)):428-435 doi:10.5863/1551-6776-27.5.428.

    PMID: 35845561
  59. 59

    Calcineurin Controls Hypothalamic NMDA Receptor Activity and Sympathetic Outflow.

    Zhou JJ, Shao JY, Chen SR, Pan HL

    Circulation research 2022; (131(4)):345-360 doi:10.1161/CIRCRESAHA.122.320976.

    PMID: 35862168
  60. 60

    Targeting inflammation and immune activation to improve CTLA4-Ig-based modulation of transplant rejection.

    Iglesias M, Brennan DC, Larsen CP, Raimondi G

    Frontiers in immunology 2022; (13()):926648 doi:10.3389/fimmu.2022.926648.

    PMID: 36119093
  61. 61

    CD44 as a pathological marker for the early detection of calcineurin inhibitor-induced nephrotoxicity post kidney transplantation.

    Hayashi A, Okamoto T, Nio-Kobayashi J, et al.

    Biomedical research (Tokyo, Japan) 2022; (43(5)):181-186 doi:10.2220/biomedres.43.181.

    PMID: 36244796
  62. 62

    Radiologic findings of biliary complications post liver transplantation.

    Khot R, Morgan MA, Nair RT, et al.

    Abdominal radiology (New York) 2023; (48(1)):166-185 doi:10.1007/s00261-022-03714-y.

    PMID: 36289069
  63. 63

    Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients.

    Rabbani A, Aliabbar S, Nikeghbalian S, et al.

    Caspian journal of internal medicine 2022; (13(4)):721-727 doi:10.22088/cjim.13.4.721.

    PMID: 36420336
  64. 64

    Infections after organ transplantation and immune response.

    Elalouf A

    Transplant immunology 2023; (77()):101798 doi:10.1016/j.trim.2023.101798.

    PMID: 36731780
  65. 65

    Scanxiety among Adults with Cancer: A Scoping Review to Guide Research and Interventions.

    Derry-Vick HM, Heathcote LC, Glesby N, et al.

    Cancers 2023; (15(5)) doi:10.3390/cancers15051381.

    PMID: 36900174
  66. 66

    Scanxiety Conversations on Twitter: Observational Study.

    Bui KT, Li Z, Dhillon HM, et al.

    JMIR cancer 2023; (9()):e43609 doi:10.2196/43609.

    PMID: 37074770
  67. 67

    Non-melanoma skin cancer of the head and neck.

    Roland N, Memon A

    British journal of hospital medicine (London, England : 2005) 2023; (84(4)):1-10 doi:10.12968/hmed.2021.0126.

    PMID: 37127417
  68. 68

    Endoplasmic reticulum stress in the adipose tissue and monocyte chemoattractant protein-1 are involved in tacrolimus-induced diabetes mellitus.

    Sun X, Wang H, Chi J, et al.

    Pharmacology research & perspectives 2023; (11(3)):e01081 doi:10.1002/prp2.1081.

    PMID: 37195045
  69. 69

    Dual Antibody Treatment for Simultaneous Acute Cellular Rejection and Antibody-Mediated Rejection After Liver Transplantation: A Case Report.

    Furukawa K, Haruki K, Kasahara M, et al.

    Transplantation proceedings 2023; (55(8)):1938-1942 doi:10.1016/j.transproceed.2023.03.093.

    PMID: 37481392
  70. 70

    IL-21-producing effector Tfh cells promote B cell alloimmunity in lymph nodes and kidney allografts.

    Zhang H, Cavazzoni CB, Podestà MA, et al.

    JCI insight 2023; (8(20)).

    PMID: 37870962
  71. 71

    Adverse Drug Events after Kidney Transplantation.

    Rostaing L, Jouve T, Terrec F, et al.

    Journal of personalized medicine 2023; (13(12)) doi:10.3390/jpm13121706.

    PMID: 38138933
  72. 72

    Tacrolimus Pharmacotherapy: Infectious Complications and Toxicity in Organ Transplant Recipients; An Updated Review.

    Tolou-Ghamari Z, Palizban AA

    Current drug research reviews 2025; (17(2)):301-310 doi:10.2174/0125899775259326231212073240.

    PMID: 38151846
  73. 73

    Scanxiety and quality of life around follow-up imaging in patients with unruptured intracranial aneurysms: a prospective cohort study.

    Kamphuis MJ, van der Kamp LT, van Eijk RPA, et al.

    European radiology 2024; (34(9)):6018-6025 doi:10.1007/s00330-024-10602-0.

    PMID: 38311702
  74. 74

    Immune Checkpoint Inhibitors in Recipients of Renal Allografts.

    Venkataraman K, Salehi T, Carroll RP

    Seminars in nephrology 2024; (44(1)):151500 doi:10.1016/j.semnephrol.2024.151500.

    PMID: 38548484
  75. 75

    Safety and efficacy of semaglutide in post kidney transplant patients with type 2 diabetes or Post-Transplant diabetes.

    Mahzari MM, Alluhayyan OB, Almutairi MH, et al.

    Journal of clinical & translational endocrinology 2024; (36()):100343 doi:10.1016/j.jcte.2024.100343.

    PMID: 38623181
  76. 76

    From the Clinical to the Bench: Exploring the Insulin Modulation Effects of Tacrolimus and Belatacept.

    Perrier Q, Cottet-Rouselle C, de-Beaumont M, et al.

    Cell transplantation 2024; (33()):9636897241246577 doi:10.1177/09636897241246577.

    PMID: 38646716
  77. 77

    Immunosuppression with cyclosporine versus tacrolimus shows distinctive nephrotoxicity profiles within renal compartments.

    Demirci H, Popovic S, Dittmayer C, et al.

    Acta physiologica (Oxford, England) 2024; (240(8)):e14190 doi:10.1111/apha.14190.

    PMID: 38884453
  78. 78

    Live Vaccine and Varicella Postexposure Prophylaxis in Pediatric Liver Transplant Recipients: A Survey of Practice in Australia and New Zealand.

    Bonett E, Doyle R, Roberts A, Wen SCH

    Pediatric transplantation 2024; (28(5)):e14833 doi:10.1111/petr.14833.

    PMID: 39039719
  79. 79

    Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN).

    Goutaudier V, Danger R, Catar RA, et al.

    Kidney international 2024; (106(5)):943-960 doi:10.1016/j.kint.2024.07.027.

    PMID: 39197587
  80. 80

    Immunopathology of lung transplantation: from infection to rejection and vice versa.

    Righi I, Barone I, Rosso L, et al.

    Frontiers in immunology 2024; (15()):1433469 doi:10.3389/fimmu.2024.1433469.

    PMID: 39286256
  81. 81

    Prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients.

    Pollack S, Plonsky M, Tibi R, et al.

    Pediatric nephrology (Berlin, Germany) 2025; (40(3)):829-834 doi:10.1007/s00467-024-06522-2.

    PMID: 39373867
  82. 82

    Cancer mortality among solid organ transplant recipients: A systematic review and meta-analysis.

    Wang Z, Deng L, Hou W, et al.

    Preventive medicine 2024; (189()):108161 doi:10.1016/j.ypmed.2024.108161.

    PMID: 39491730
  83. 83

    BK Polyomavirus Infection in Kidney Transplantation: A Comprehensive Review of Current Challenges and Future Directions.

    Nourie N, Boueri C, Tran Minh H, et al.

    International journal of molecular sciences 2024; (25(23)) doi:10.3390/ijms252312801.

    PMID: 39684510
  84. 84

    Azathioprine and risk of non-melanoma skin cancers in organ transplant recipients: a systematic review and update meta-analysis.

    Kreuz M, Cardoso JCO, Sobreira LER, et al.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2025; (27(7)):3100-3109 doi:10.1007/s12094-024-03839-0.

    PMID: 39825996
  85. 85

    Letermovir use for cytomegalovirus prophylaxis following lung transplantation: A single-center review.

    Mezochow AK, He KD, Whitaker K, et al.

    JHLT open 2024; (6()):100149 doi:10.1016/j.jhlto.2024.100149.

    PMID: 40145049
  86. 86

    Novel insights and an updated review of metabolic syndrome in immune-mediated organ transplant rejection.

    Tao Z, Luo Z, Zou Z, et al.

    Frontiers in immunology 2025; (16()):1580369 doi:10.3389/fimmu.2025.1580369.

    PMID: 40330480
  87. 87

    Genomic and Biomarker Innovations in Predicting Kidney Transplant Rejection.

    Punukollu R, Parajuli S, Chaudhari H, Mour G

    Journal of clinical medicine 2025; (14(11)) doi:10.3390/jcm14113642.

    PMID: 40507402
  88. 88

    Clinical events and healthcare resource utilization associated with neutropenia and leukopenia among adult kidney transplant recipients receiving valganciclovir.

    Beyer AP, Moise PA, Wong M, et al.

    World journal of transplantation 2025; (15(2)):102671 doi:10.5500/wjt.v15.i2.102671.

    PMID: 40535505
  89. 89

    Mitigating cardiac allograft vasculopathy in a murine model via CD40-TRAF6 blockade and cyclosporin A synergy.

    Huang Y, Lai J, Chen X, et al.

    Scientific reports 2025; (15(1)):22327 doi:10.1038/s41598-025-08315-5.

    PMID: 40595221
  90. 90

    CCR2 and TLR3: noninvasive macrophage-associated biomarkers of acute renal transplant rejection.

    Wang S, Pan X, Peng J, et al.

    Renal failure 2025; (47(1)):2532856 doi:10.1080/0886022X.2025.2532856.

    PMID: 40716784
  91. 91

    Analysis of risk factors for Epstein-Barr virus reactivation and progression to post-transplant lymphoproliferative disorder in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.

    Jia L, Yang H, Zhou Y, et al.

    Frontiers in pediatrics 2025; (13()):1627990 doi:10.3389/fped.2025.1627990.

    PMID: 40746349
  92. 92

    Local Graft Irradiation to Treat Refractory Acute Rejection in Pediatric and Young Adult Kidney Transplant Patients: A Case Series and Review of the Literature.

    Hite CM, Varnell CD, VandenHeuvel KA, et al.

    Pediatric transplantation 2025; (29(6)):e70132 doi:10.1111/petr.70132.

    PMID: 40785033
  93. 93

    Incidence and risk factors of post-transplant diabetes mellitus among kidney transplant recipients: a retrospective study from a tertiary center in Saudi Arabia.

    Alotaibi M, Almalki N, Alotaibi ME, et al.

    BMC nephrology 2025; (26(1)):460 doi:10.1186/s12882-025-04375-x.

    PMID: 40804369
  94. 94

    Aspects of Self-Management After Solid Organ Transplantation-A Scoping Review.

    Jobst S, Kugler C, Rebafka A

    Nursing reports (Pavia, Italy) 2025; (15(8)) doi:10.3390/nursrep15080304.

    PMID: 40863691
  95. 95

    Bacterial Bloodstream Infections After Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide.

    Chorão P, de Cossio S, Muñoz-Brell P, et al.

    Transplantation and cellular therapy 2025; doi:10.1016/j.jtct.2025.09.019.

    PMID: 40946741
  96. 96

    Debilitating musculoskeletal pain after solid organ transplantation: an under-recognised and serious condition associated with common immunosuppressive drug therapy.

    Smith S, Dickson B, Fitzgerald S, Murray JS

    BMJ case reports 2025; (18(9)) doi:10.1136/bcr-2025-266427.

    PMID: 40954044
  97. 97

    Can GLP-1RAs redefine transplantation standard of care?

    Almalki BA

    Trends in pharmacological sciences 2025; (46(11)):1056-1071 doi:10.1016/j.tips.2025.08.013.

    PMID: 40973569
  98. 98

    Prevalence, severity, and modifiable predictors of scanxiety in patients undergoing routine oncologic imaging: a prospective longitudinal study.

    Shah MS, Memon JA, Malik U, et al.

    Clinical imaging 2025; (128()):110634 doi:10.1016/j.clinimag.2025.110634.

    PMID: 41077027
  99. 99

    Post-Transplant Metabolic Syndrome in Pediatric Liver Transplant Recipients-Contributors, Screening, and Management.

    Buytaert M, Braekman E, Van Overbeke K, et al.

    Pediatric transplantation 2025; (29(8)):e70218 doi:10.1111/petr.70218.

    PMID: 41199651
  100. 100

    Tacrolimus toxicity in kidney transplant recipient after wedge liver resection: A case report and review of literature.

    Naiyarakseree N, Wuttiputhanun T, Townamchai N, et al.

    World journal of nephrology 2025; (14(4)):111723 doi:10.5527/wjn.v14.i4.111723.

    PMID: 41479815
  101. 101

    Non-Melanoma Skin Cancer in Transplant Recipients: A Single-Centre Retrospective Cohort Study on the Role of Transplant Type, Immunosuppressive Exposure, and Tumor Subtypes.

    Zengarini C, Tagnin V, Sorbi G, et al.

    Clinical transplantation 2026; (40(2)):e70451 doi:10.1111/ctr.70451.

    PMID: 41615235